Massimo Massaia
Overview
Explore the profile of Massimo Massaia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
86
Citations
2141
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Castellino A, Comba L, Bertolotti L, Boccomini C, Clerico M, Nicoli P, et al.
Ann Hematol
. 2025 Mar;
PMID: 40074837
The SARS-CoV2 pandemic has posed unprecedented challenges between temporary or permanent discontinuation of immunosuppressive treatment to protect patients, or disease control prioritization by not interrupting treatment. Maintenance treatment with anti-CD20...
2.
Boccadoro M, Corradini P, Massaia M, Tarella C
Haematologica
. 2025 Feb;
110(2):267.
PMID: 39895331
No abstract available.
3.
Stella F, Pennisi M, Chiappella A, Casadei B, Bramanti S, Ljevar S, et al.
Transplant Cell Ther
. 2025 Jan;
PMID: 39870308
Background: Anti-CD19 CAR T-cells have revolutionized outcomes in relapsed/refractory large B-cell lymphomas. Long-term follow-up underscored the role of hematological toxicity in nonrelapse mortality, largely driven by infections, leading to the...
4.
Stella F, Chiappella A, Magni M, Bonifazi F, De Philippis C, Musso M, et al.
Br J Haematol
. 2024 Dec;
206(2):644-651.
PMID: 39710966
Brexucabtagene autoleucel (brexu-cel) has revolutionized the treatment of patients affected by mantle cell lymphomas. In this prospective, observational multicentre study, we evaluated 106 patients, with longitudinal brexu-cel kinetics in peripheral...
5.
Giannotta J, Artoni A, Mancini I, Agosti P, Carpenedo M, Truma A, et al.
J Thromb Haemost
. 2024 Nov;
23(2):704-716.
PMID: 39549837
Background: Immune-mediated thrombotic thrombocytopenic purpura (iTTP) patients are not responsive to standard rituximab in approximately 10% to 15% of cases, and oral immunosuppressants showed controversial results with significant toxicity. Targeting...
6.
Ziccheddu B, Giannotta C, DAgostino M, Bertuglia G, Saraci E, Oliva S, et al.
Blood Cancer J
. 2024 Jul;
14(1):117.
PMID: 39030183
Targeted immunotherapy combinations, including the anti-CD38 monoclonal antibody (MoAb) daratumumab, have shown promising results in patients with relapsed/refractory multiple myeloma (RRMM), leading to a considerable increase in progression-free survival. However,...
7.
Stella F, Chiappella A, Casadei B, Bramanti S, Ljevar S, Chiusolo P, et al.
Blood Cancer Discov
. 2024 Jul;
5(5):318-330.
PMID: 38953781
This real-world prospective observational study across 21 Italian centers (CART-SIE) compares axicabtagene ciloleucel (axi-cel) and tisagenlecleucel (tisa-cel) outcomes in 485 patients with relapsed/refractory large B-cell lymphoma with baseline characteristics matched...
8.
Guerra L, Chauvie S, Fallanca F, Bergesio F, Marcheselli L, Durmo R, et al.
Eur J Nucl Med Mol Imaging
. 2024 May;
51(11):3311-3321.
PMID: 38795120
Purpose: To evaluate the reliability of the Deauville score (DS) in therapy response assessment and to define the prognostic value of the metabolic response of end of induction (EOI) [F]FDG...
9.
Rigo A, Vaisitti T, Laudanna C, Terrabuio E, Micillo M, Frusteri C, et al.
Cell Death Dis
. 2024 May;
15(5):323.
PMID: 38724507
Richter's syndrome (RS) is the transformation of chronic lymphocytic leukemia (CLL) into a high-grade B-cell malignancy. Molecular and functional studies have pointed out that CLL cells are close to the...
10.
Mauro F, Scalzulli P, Scarfo L, Minoia C, Murru R, Sportoletti P, et al.
Cancers (Basel)
. 2024 Mar;
16(6).
PMID: 38539561
Real-world data in clinical practice are needed to confirm the efficacy and safety that ibrutinib has demonstrated in clinical trials of patients with chronic lymphocytic leukemia (CLL). We described the...